TSHA financials
Taysha Gene Therapies (TSHA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TSHA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $9.77M | $9.77M | -$110.50M | -$109.00M | -0.34 |
| 2024 | $8.33M | $8.33M | -$91.46M | -$89.30M | -0.36 |
| 2023 | $15.45M | $15.45M | -$72.44M | -$111.57M | -0.96 |
| 2022 | $2.50M | $15.00K | -$126.03M | -$166.01M | -3.78 |
| 2021 | $0.00 | $0.00 | -$173.27M | -$174.52M | -4.64 |
| 2020 | $0.00 | -$9.00K | -$43.00M | -$43.00M | -3.40 |
- TSHA revenue was $9.77M in fiscal 2025, net income -$109.00M.
Updated 2026-11-07 11:54 UTC